WinRho SDF News
Cangene reports results for first quarter of fiscal 2008 - Trading Markets (press release)
Comparatively lower sales of WinRho(R) SDF and reduced royalties during the quarter were offset by increases in R&D-services revenues from agreements with ...
Cangene Reports Results for First Quarter of Fiscal 2008 - PharmaLive.com (press release)
Comparatively lower sales of WinRho(R) SDF and reduced royalties during the quarter were offset by increases in R&D-services revenues from agreements with ...
Cangene announces approval of liquid formulation of WinRho(R) SDF ... - Canada NewsWire (press release)
28 /CNW/ - Cangene Corporation today announces that Health Canada has approved the liquid formulation of Cangene's WinRho(R) SDF (Rho(D) Immune Globulin ...
Cangene announces approval of liquid formulation of winrho(R) SDF ... - Canada NewsWire (press release)
28 /CNW/ - Cangene Corporation today announces that Health Canada has approved the liquid formulation of Cangene's winrho(R) SDF (Rho(D) Immune Globulin ...
Cangene announces fiscal 2007 financial results - Canada NewsWire (press release)
Stronger year-over-year winrho(R) SDF sales in the US and the commencement of hepagam B(TM) sales partially offset reduced revenues from VIG - last year ...
Cangene announces fiscal 2007 financial results - CNW Telbec (Communiqués de presse)
Stronger year-over-year WinRho(R) SDF sales in the US and the commencement of HepaGam B(TM) sales partially offset reduced revenues from VIG - last year ...
Cangene annual profit down 23 per cent on revenue slippage, C$ hit ... - The Chronicle Journal
Gross profit swelled to $50 million or 54 per cent of revenue from $48.4 million or 44 per cent of revenue, thanks to stronger US sales of WinRho SDF, ...
Cangene announces fiscal 2007 financial results - Canada NewsWire (press release)
Stronger year-over-year WinRho(R) SDF sales in the US and the commencement of HepaGam B(TM) sales partially offset reduced revenues from VIG - last year ...
Cangene's heptavalent botulism antitoxin delivered and accepted ... - CNW Telbec (Communiqués de presse)
The Company has been manufacturing its WinRho(R) SDF hyperimmune product for more than 25 years, which has established the manufacturing technology. ...
Cangene's anthrax immune globulin delivered and accepted into US ... - Canada NewsWire (press release)
The Company has been manufacturing its WinRho(R) SDF hyperimmune product for more than 25 years, which has established the manufacturing technology. ...
WinRho SDF RSS Feed